Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.200
-0.050 (-2.22%)
At close: Apr 28, 2026, 4:00 PM EDT
2.160
-0.040 (-1.82%)
After-hours: Apr 28, 2026, 6:30 PM EDT
Century Therapeutics Employees
Century Therapeutics had 78 employees as of December 31, 2025. The number of employees decreased by 72 or -48.00% compared to the previous year.
Employees
78
Change (1Y)
-72
Growth (1Y)
-48.00%
Revenue / Employee
$1,399,538
Profits / Employee
-$122,821
Market Cap
396.13M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 78 | -72 | -48.00% |
| Dec 31, 2024 | 150 | -15 | -9.09% |
| Dec 31, 2023 | 165 | -19 | -10.33% |
| Dec 31, 2022 | 184 | -4 | -2.13% |
| Dec 31, 2021 | 188 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Rocket Pharmaceuticals | 202 |
| Invivyd | 122 |
| Enanta Pharmaceuticals | 120 |
| Niagen Bioscience | 117 |
| Neumora Therapeutics | 96 |
| Lineage Cell Therapeutics | 77 |
| PureTech Health | 56 |
IPSC News
- 7 weeks ago - Century Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Century Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Century Therapeutics to Participate in Upcoming Investor Conferences in March - GlobeNewsWire
- 2 months ago - IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewsWire
- 5 months ago - Century Therapeutics Transcript: Piper Sandler 37th Annual Healthcare Conference - Transcripts
- 5 months ago - Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 5 months ago - Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes - GlobeNewsWire